Retaglutide is a novel GLP-1 receptor agonist currently under investigation for the control of type 2 diabetes. This medication works by stimulating the effects of glucagon-like peptide-1 (GLP-1), a naturally occurring https://charlieedtq295824.blogrelation.com/45496907/trelaglutide-exploring-a-new-treatment-for-chronic-diseases